TeleflexTFX +0.25%75 EV-to-FCF is 36.71 as of Jul. 06, 2026, which is 5% above its 10-year median of 35.06. GuruFocus rates TFX with a GF Score™ of 75/100 and a GF Value™ of $181.17 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 417 Medical Devices & Instruments companies, Teleflex ranks worse than 66.19% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Teleflex's Enterprise Value is $8,323 Mil.
Teleflex's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $227 Mil. Therefore, Teleflex's EV-to-FCF for today is 36.71.
The historical rank and industry rank for Teleflex's EV-to-FCF or its related term are showing as below:
TFX'
s EV-to-FCF Range Over the Past 10 Years
Min: 13.71 Med: 35.06 Max: 74.92
Current: 36.71
During the past 13 years, the highest EV-to-FCF of Teleflex was 74.92. The lowest was 13.71. And the median was 35.06.
TFX's EV-to-FCF is ranked worse than 66.19% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 23.54
vs TFX: 36.71
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Teleflex's share price for today is $134.32.
Teleflex's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-22.800.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Teleflex EV-to-FCF Related Terms
Teleflex EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Teleflex's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Teleflex's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Teleflex EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Teleflex's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Teleflex's EV-to-FCF falls into.
Teleflex's current Enterprise Value is $8,323 Mil.
Teleflex's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $227 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teleflex (TFX) has a EV-to-FCF of 36.71 as of Jul. 06, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Teleflex and its competitors. This is near median its historical median of 35.06. Over the past decade, Teleflex's EV-to-FCF has ranged from 13.71 to 74.92. According to the industry distribution chart, Teleflex ranks #276 out of 417 companies in the Medical Devices & Instruments industry, placing it in the top 66.2%.
Is Teleflex's EV-to-FCF too high?
Teleflex's current EV-to-FCF of 36.71 is near median its 10-year median of 35.06. Over the past 10 years, this metric has ranged from a low of 13.71 to a high of 74.92. The Medical Devices & Instruments industry median EV-to-FCF is 23.54. Teleflex's value of 36.71 is 55.9% above this industry median. Based on the distribution chart, Teleflex ranks #276 out of 417 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Teleflex has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Teleflex's EV-to-FCF compare to STVN and AVTR?
According to the Medical Devices & Instruments industry distribution chart, Teleflex ranks #276 out of 417 companies for EV-to-FCF. This places Teleflex in the lower half of its industry. The industry median EV-to-FCF is 23.54. Teleflex's value of 36.71 is 55.9% above this benchmark. Historically, Teleflex's own EV-to-FCF has ranged from 13.71 to 74.92 over the past decade. While the company's 10-year median is 35.06 vs. the industry median of 23.54, Teleflex has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.54, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Teleflex's current EV-to-FCF of 36.71 is 55.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Teleflex and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Teleflex's current EV-to-FCF is 36.71, which is near median its own 10-year median of 35.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teleflex stock overvalued right now?
Based on GuruFocus' analysis, Teleflex (TFX) is currently considered Modestly Undervalued. The stock's GF Value™ is $181.17, compared to a current price of $134.32 — trading 25.9% below its estimated fair value. The current EV-to-FCF is 36.71, which is near median its 10-year median of 35.06 and 55.9% above the Medical Devices & Instruments industry median of 23.54. Teleflex's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Teleflex (TFX), the current EV-to-FCF is 36.71 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Teleflex (TFX) Overvalued in 2026?
Based on GuruFocus' analysis, Teleflex stock appears to be undervalued.
The current stock price of $134.32 is trading 25.9% below its estimated GF Value™ of $181.17.
GuruFocus considers Teleflex to be Modestly Undervalued.
Key valuation signals for TFX:
EV-to-FCF: 36.71 (near median its 10-year median of 35.06)
GF Value™: $181.17 vs. price of $134.32 (25.9% below fair value)
Industry Position: 55.9% above the Medical Devices & Instruments median (#276 of 417)
No single metric tells the full story. See the TFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
75GF Score
Get the complete analysis for TFX
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TFX has been successfully added to your 
